Breaking News Instant updates and real-time market news.

PRTK

Paratek Pharmaceuticals

$6.94

-0.04 (-0.57%)

16:08
11/06/18
11/06
16:08
11/06/18
16:08

Paratek Pharmaceuticals reports Q3 EPS ($1.01), consensus (84c)

Based upon its current operating plan, Paratek anticipates that its existing cash, cash equivalents and marketable securities of $310.9M as of September 30, estimated Nuzyra product sales, and estimated royalty payments from its collaboration with Almirall, LLC will enable it to fund its operating expenses, capital expenditures, and debt service through Q1 of 2021.

  • 06

    Nov

PRTK Paratek Pharmaceuticals
$6.94

-0.04 (-0.57%)

08/27/18
BOFA
08/27/18
INITIATION
Target $13
BOFA
Neutral
Paratek Pharmaceuticals initiated with a Neutral at BofA/Merrill
BofA/Merrill analyst Jason Gerberry initiated Paratek Pharmaceuticals with a Neutral and $13 price target.
08/09/18
WEDB
08/09/18
NO CHANGE
Target $20
WEDB
Tone of Paratek advisory committee meeting 'extremely positive,' says Wedbush
Wedbush analyst Robert Driscoll said the tone of yesterday's antimicrobials drug advisory committee meeting was "extremely positive" regarding to the data presented by Paratek and he expects full approval of omadacycline for the treatment of both acute bacterial skin infections and community-acquired bacterial pneumonia in early October. He believes the flexible dosing, low risk of C. difficile and lack of drug-drug interactions will support significant commercial success of omadacycline. Driscoll keeps an Outperform rating and $20 price target on Paratek shares.
08/08/18
RAJA
08/08/18
NO CHANGE
RAJA
Outperform
AdCom vote increases chances of Paratek's omadacycline approval, says Raymond James
Raymond James analyst Laura Chico notes that the FDA's Advisory Committee voted 17-1 in favor of approval for Paratek Pharmaceuticals' omadacycline in skin infections and 14-4 in favor of approval in pneumonia. While the analyst acknowledges that the FDA is not bound by the committee's decision, they nearly always follow the recommendation. Thus, she thinks the vote incrementally increases the chances for an omadacycline approval. Chico reiterates an Outperform rating on the shares.
08/06/18
HCWC
08/06/18
NO CHANGE
Target $55
HCWC
Buy
Paratek risk/reward favorable into Wednesday's panel, says H.C. Wainwright
H.C. Wainwright analyst Ed Arce believes the risk/reward for Paratek Pharmaceuticals is "positively-skewed" into Wednesday's FDA panel meeting for omadacycline. The analyst expects a "relatively smooth" panel and would be buyers of the stock heading into the early October FDA action date. Arce keeps a Buy rating on Paratek with a $55 price target.

TODAY'S FREE FLY STORIES

XPO

XPO Logistics

$52.01

-7.535 (-12.65%)

, AMZN

Amazon.com

$1,608.88

-13.47 (-0.83%)

08:34
02/19/19
02/19
08:34
02/19/19
08:34
Recommendations
XPO Logistics, Amazon.com analyst commentary  »

XPO Logistics investment…

XPO

XPO Logistics

$52.01

-7.535 (-12.65%)

AMZN

Amazon.com

$1,608.88

-13.47 (-0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 03

    Mar

  • 18

    Mar

GVP

GSE Systems

$2.84

-0.02 (-0.70%)

08:34
02/19/19
02/19
08:34
02/19/19
08:34
Hot Stocks
GSE Systems acquires DP Engineering for $13.5M in cash »

GSE Systems announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPC

Genuine Parts

$107.49

1.7447 (1.65%)

08:33
02/19/19
02/19
08:33
02/19/19
08:33
Hot Stocks
Genuine Parts CEO says 'we ended the fourth quarter with positive momentum' »

Paul Donahue, President…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 04

    Apr

NSP

Insperity

$129.76

4.61 (3.68%)

08:33
02/19/19
02/19
08:33
02/19/19
08:33
Recommendations
Insperity analyst commentary  »

Insperity price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBAY

CymaBay

$9.97

0.195 (2.00%)

08:33
02/19/19
02/19
08:33
02/19/19
08:33
Hot Stocks
CymaBay announces early completion of enrollment for seladelpar study »

CymaBay announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABBV

AbbVie

$80.85

0.355 (0.44%)

08:33
02/19/19
02/19
08:33
02/19/19
08:33
Hot Stocks
AbbVie announces FDA accepted for priority review NDA for upadacitinib »

AbbVie has announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 18

    May

GPC

Genuine Parts

$107.49

1.7447 (1.65%)

08:33
02/19/19
02/19
08:33
02/19/19
08:33
Hot Stocks
Genuine Parts reports Q4 total sales included 4.6% comparable growth »

Total sales for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 04

    Apr

HAS

Hasbro

$86.43

-3.29 (-3.67%)

08:32
02/19/19
02/19
08:32
02/19/19
08:32
Conference/Events
Hasbro management to meet with KeyBanc »

Group luncheon meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 19

    Feb

  • 19

    Feb

  • 19

    Feb

  • 06

    Mar

  • 28

    May

GPC

Genuine Parts

$107.49

1.7447 (1.65%)

08:31
02/19/19
02/19
08:31
02/19/19
08:31
Earnings
Genuine Parts sees FY19 adjusted EPS $5.81-$5.96, consensus $5.95 »

The company is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 04

    Apr

PFE

Pfizer

$42.41

0.45 (1.07%)

08:31
02/19/19
02/19
08:31
02/19/19
08:31
Hot Stocks
Gliknik to receive $15M milestone payment from Pfizer »

Gliknik announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 18

    May

CHMA

Chiasma

$3.75

(0.00%)

08:31
02/19/19
02/19
08:31
02/19/19
08:31
Initiation
Chiasma initiated  »

Chiasma initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PPG

PPG

$109.11

1.8 (1.68%)

08:30
02/19/19
02/19
08:30
02/19/19
08:30
Hot Stocks
PPG announces $10M investment in South Carolina coatings services facility »

PPG announced a $10M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

GPC

Genuine Parts

$107.49

1.7447 (1.65%)

08:30
02/19/19
02/19
08:30
02/19/19
08:30
Earnings
Genuine Parts reports Q4 adjusted EPS $1.35, consensus $1.31 »

Reports Q4 revenue $4.6B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 04

    Apr

BEST

Best Inc

$5.89

-0.08 (-1.34%)

, AHL

Aspen Insurance

$42.74

(0.00%)

08:30
02/19/19
02/19
08:30
02/19/19
08:30
Options
One new option listing and twelve option delistings on February 19th »

New option listings for…

BEST

Best Inc

$5.89

-0.08 (-1.34%)

AHL

Aspen Insurance

$42.74

(0.00%)

BSTI

Best Inc.

$5.89

-0.08 (-1.34%)

EMMS

Emmis Communications

$3.75

(0.00%)

HECO

Hallwood Energy

$40.54

(0.00%)

ISSC

Innovative Solutions

$2.70

0.05 (1.89%)

LOXO

Loxo Oncology

$234.66

(0.00%)

MB

Acquired by Vista Equity Partners

$36.46

(0.00%)

MBIN

Merchants Bancorp

$21.45

1.39 (6.93%)

MBTF

MBT Financial

$11.04

0.29 (2.70%)

SEED

Origin Agritech

$6.79

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:30
02/19/19
02/19
08:30
02/19/19
08:30
General news
U.S. equities are modestly weaker »

U.S. equities are…

CERC

Cerecor

$5.09

0.52 (11.38%)

08:29
02/19/19
02/19
08:29
02/19/19
08:29
Hot Stocks
Cerecor receives fast track designation for CERC-801 for PGM1 deficiency »

Cerecor announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLT

Hilton

$81.82

1.67 (2.08%)

08:29
02/19/19
02/19
08:29
02/19/19
08:29
Recommendations
Hilton analyst commentary  »

Hilton price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$100.00

1.52 (1.54%)

08:28
02/19/19
02/19
08:28
02/19/19
08:28
Hot Stocks
Breaking Hot Stocks news story on Walmart »

Walmart says sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 03

    Mar

  • 06

    Mar

CNSL

Consolidated Communications

$10.39

0.39 (3.90%)

, WIN

Windstream

$3.37

0.2 (6.31%)

08:27
02/19/19
02/19
08:27
02/19/19
08:27
Downgrade
Consolidated Communications, Windstream rating change  »

Consolidated…

CNSL

Consolidated Communications

$10.39

0.39 (3.90%)

WIN

Windstream

$3.37

0.2 (6.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 25

    Feb

FTR

Frontier Communications

$2.65

0.28 (11.81%)

08:27
02/19/19
02/19
08:27
02/19/19
08:27
Downgrade
Frontier Communications rating change  »

Frontier Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 26

    Feb

UNIT

Uniti Group

$20.00

0.53 (2.72%)

08:27
02/19/19
02/19
08:27
02/19/19
08:27
Downgrade
Uniti Group rating change  »

Uniti Group downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 11

    Mar

WIN

Windstream

$3.37

0.2 (6.31%)

08:27
02/19/19
02/19
08:27
02/19/19
08:27
Downgrade
Windstream rating change  »

Windstream downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

08:26
02/19/19
02/19
08:26
02/19/19
08:26
Conference/Events
CFA Society of New York to hold a roundtable »

Investment Strategy…

WMT

Walmart

$100.00

1.52 (1.54%)

08:26
02/19/19
02/19
08:26
02/19/19
08:26
Hot Stocks
Breaking Hot Stocks news story on Walmart »

Walmart sees FY20 EPS up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 03

    Mar

  • 06

    Mar

UNH

UnitedHealth

$271.03

5.795 (2.18%)

08:25
02/19/19
02/19
08:25
02/19/19
08:25
Conference/Events
Economic Club of Minnesota to hold a luncheon meeting »

Group Luncheon Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 28

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.